Sickle Cell Anemia Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Sickle Cell Anemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting

Blood Sampling for Research Related to Sickle Cell Disease

Sickle Cell DiseaseSickle Cell TraitSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)250 enrolled1 locationNCT00542230
Recruiting
Phase 1

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

Sickle Cell DiseaseHb-SS DiseaseHemoglobin S+3 more
National Heart, Lung, and Blood Institute (NHLBI)25 enrolled1 locationNCT05904093
Recruiting

Serial Assessment of Fertility Experiences

Sickle Cell Anemia
Children's Hospital Medical Center, Cincinnati250 enrolled3 locationsNCT07116772
Recruiting
Phase 1

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

Beta-ThalassemiaSickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)+1 more
Daniel Bauer10 enrolled1 locationNCT06647979
Recruiting
Phase 2

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Sickle Cell DiseaseOsteonecrosisAvascular Necrosis+2 more
University of California, Davis30 enrolled1 locationNCT06016634
Recruiting

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Sickle Cell DiseaseSickle Cell AnemiaMeasles Vaccination
Children's Hospital Medical Center, Cincinnati130 enrolled3 locationsNCT07356050
Recruiting
Phase 4

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

Sickle Cell Anemia (HbSS)Sickle-β0-thalassemia (HbSβ0)
Children's Hospital Medical Center, Cincinnati50 enrolled1 locationNCT07177300
Recruiting
Phase 1Phase 2

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Sickle Cell Anemia
Paul Szabolcs5 enrolled1 locationNCT03653338
Recruiting

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Sickle Cell DiseaseSickle Cell Anemia
Children's Hospital Medical Center, Cincinnati200 enrolled1 locationNCT04093986
Recruiting
Phase 3

Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa

Sickle Cell DiseaseSickle Cell Anemia in Children
Brown University400 enrolled1 locationNCT05285917
Recruiting
Not Applicable

Pressure Pain Tolerance in Relation to Balance and Strength in Children

Sickle Cell Anemia
Adly A Adam80 enrolled1 locationNCT06529874
Recruiting
Phase 2

A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD

Sickle Cell DiseaseSickle Cell DisordersSickle Cell Anemia+3 more
University of Regensburg212 enrolled9 locationsNCT04201210
Recruiting
Not Applicable

Low Systemic/High Local Exercise Load in Peds SCD

Sickle Cell Anemia in Children
University of Mississippi Medical Center60 enrolled1 locationNCT06387758